PRCT

Procept Biorobotics
$20.07
−$0.67 (−3.23%)Sep 10, 2026
1.9PoorMoatMint rating

MoatMint rates Procept Biorobotics (PRCT) 1.9 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 4.3 out of 10.

Key metrics

The numbers that frame PRCT today
Market cap
$1.15B
P/E (TTM)
-10.5
EV / FCF
-11.8
Gross margin
64.2%
EV / Sales
3.0
ROIC
-47.5%
Div yield
0%
Debt / equity
0.2
52wk Low
$16.67
52wk High
$40.10

PRCT stock rating

How PRCT scores on quality, value, growth, momentum and financial health
1.9out of 10
Low overallNeutral business, expensive price
Quality4.3
Growth3.5
Momentum1.6
Value2.4
Financial Health3.3

Growth

Revenue and earnings trend for PRCT
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about PRCT
Is Procept Biorobotics a good buy?
No. Procept Biorobotics has weak quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Procept Biorobotics is selling at a very high price.
What is the market capitalization of PRCT?
Procept Biorobotics's market capitalization is $1.15B.
What is the P/E ratio for PRCT stock?
Procept Biorobotics's current P/E ratio is -10.5.
What is the 52-week high for PRCT stock?
The 52-week high for Procept Biorobotics is $40.10. The current close of $20.07 is 50% below that high.
What is the 52-week low for PRCT stock?
The 52-week low for Procept Biorobotics is $16.67. The current close of $20.07 is 20.4% above that low.
Does PRCT stock pay dividends?
Procept Biorobotics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PRCT?
Procept Biorobotics's Debt / Equity ratio is 0.23.